Press Releases

July 31, 2019 in Press Release

NeuroPace Appoints Mark Saxton as Vice President of Sales

Industry veteran to drive business development, strategy and enhance customer experience MOUNTAIN VIEW, Calif. — July 30, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Mark Saxton as the company’s Vice President of Sales. Mr. Saxton is an accomplished medical device industry executive... Read More
July 24, 2019 in Press Release

NeuroPace Announces Michael Favet as CEO

Frank Fischer appointed Chairman of Board of Directors MOUNTAIN VIEW, Calif. – July 24, 2019 (BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Michael Favet as Chief Executive Officer. Frank Fischer, after 20 years serving as CEO, continues with NeuroPace as Chairman of the…

Read More
July 10, 2019 in Press Release

NIH Study to Utilize NeuroPace RNS® System for Research on the Brain’s Reward System

Study Aims to Assess Whether Closed-Loop Neuromodulation Could Help Manage
 Medically Refractory Obesity MOUNTAIN VIEW, Calif. — July 10, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that the company’s RNS® System, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy,... Read More
May 9, 2019 in Press Release

NeuroPace Shares Positive Data from Studies of the RNS System at the American Academy of Neurology 2019 Annual Meeting

Results Demonstrate Significant Seizure Reduction in Adults with Drug-Resistant Epilepsy; Insights into the Human Brain MOUNTAIN VIEW, Calif. — May 9, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, presented long-term clinical results demonstrating that the RNS® System for refractory epilepsy significantly reduces seizure frequency in patients, with... Read More
May 2, 2019 in Press Release

NeuroPace to Present Data from Studies of the RNS System at 2019 American Academy of Neurology Annual Meeting

Presentations to highlight nine-year treatment outcomes and research on the potential use of electrographic data to identify RNS System responders MOUNTAIN VIEW, Calif. — May 2, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that data from two studies of the company’s RNS® System for adults... Read More
February 12, 2019 in Press Release

NeuroPace Announces New Category I CPT Code from AMA for Electrocorticography from an Implanted Brain Neurostimulator

Supports Value of Insights Provided by Brain Recordings from the NeuroPace RNS® System for Drug-Resistant Epilepsy MOUNTAIN VIEW, Calif. — February 12, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT®)... Read More